Articles by David A. Wohl

Reply

Wohl, David A.; Golin, Carol E.; Napravnik, Sonia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 76(1):e21-e22, September 1st, 2017.

Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and...

Arribas, José R.; Thompson, Melanie; Sax, Paul E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(2):211-218, June 1st, 2017.

Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial

Wohl, David A.; Golin, Carol E.; Knight, Kevin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(1):81-90, May 1st, 2017.

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF ...

Wohl, David A.; Cohen, Calvin; Gallant, Joel E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):e118-e120, March 1st, 2014.

Decreasing Excess Mortality of HIV-Infected Patients Initiating Antiretroviral Therapy: Comparison with Mortality in General Population in China, 2003–2009

Zhu, Hao; Napravnik, Sonia; Eron, Joseph J.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(5):e150-e157, August 15th, 2013.

Absence of Sustained Hyperlactatemia in HIV-Infected Patients With Risk Factors for Mitochondrial Toxicity

Wohl, David A.; Pilcher, Christopher D.; Evans, Scott; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(3):274-278, March 1st, 2004.